Skip to main content
Clinical Trials/NCT06091488
NCT06091488
Completed
Not Applicable

Evaluation Of Clinical Results And Imaging Of Anterior Cruciate Ligament Reconstruction With Orthopure Xt

Istituto Ortopedico Rizzoli1 site in 1 country10 target enrollmentApril 12, 2022
ConditionsACLACL Injury

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ACL
Sponsor
Istituto Ortopedico Rizzoli
Enrollment
10
Locations
1
Primary Endpoint
Lysholm Knee Score
Status
Completed
Last Updated
7 months ago

Overview

Brief Summary

The purpose of this study is to evaluate subjective and objective clinical outcomes and imaging data of subjects undergoing reconstruction or revision of LCA reconstruction using OrthoPure XT

Registry
clinicaltrials.gov
Start Date
April 12, 2022
End Date
August 25, 2025
Last Updated
7 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients between the ages of 18 and 65 at the time of ACL reconstruction surgery;
  • Patients aged 35 to 65 at the time of primary ACL reconstruction surgery;
  • Male and female sex;
  • First injury of the ACL with impossibility of use of autograft (patellar tendinopathy, quadriceps tendinopathy, goose leg tendinopathy) or refusal to use allograft (Bank tendon);
  • Recurrence of ACL injury with impossibility of use of autograft (prior use/tendinopathy of the patellar, previous use/tendinopathy of the quadriceps, previous use/tendinopathy of the goose leg) or refusal to use allograft (tendon of Bank);

Exclusion Criteria

  • Patients who do not consent to be included in the study
  • Presence of haematological, rheumatic or haemorrhagic disease time of assessment
  • ACL primary reconstruction in subjects under 35
  • Allergies and/or reactions from hypersensitivity or religious objection to the use of porcine derivation
  • Pregnant and/or breastfeeding women

Outcomes

Primary Outcomes

Lysholm Knee Score

Time Frame: After 24 months

The final score is obtained from the sum of the various scores obtained in the different and ranges from 0 to 100. Scores are divided into subgroups: Excellent (95-100); Good (84-94); Decent (65-83); Poor (\<64).

Tegner Score

Time Frame: After 24 months

allows to estimate the level of motor activity of a subject with a score between 0 and 10, where 0 represents 'inability' and 10 represents 'participation in competitive sports

Visual Analogue Scale

Time Frame: After 24 months

is a one-dimensional quantitative pain assessment scale at 10 points; the scale requires the patient to select the number that best describes the intensity of his pain, from 0 to 10, at that precise moment. 0 means no pain and 10 indicates the worst possible pain.

continuity of the graft

Time Frame: After 24 months

assess the continuity of the graft with magnetic resonance imaging

International Knee Documentation Committee

Time Frame: After 24 months

The score goes from 0 to 100 where the maximum is 100 and expresses the absence of limitations and symptoms, and therefore an excellent result; the further you go from this score and the worse the result, which can therefore be divided into four groups: excellent (80-100)good (60-80), good (30-60), bad (0-30)

Study Sites (1)

Loading locations...

Similar Trials